Advocating for a world where intellectual
property law serves the public interest.
[Nirmalya Syam, Viviana Munoz, Carlos M. Correa and Vitor Ido] This Policy Brief reviews the role of the Doha Declaration on TRIPS and Public Health in the twenty years since its adoption. It finds that the Doha Declaration has contributed to advance the use of the TRIPS flexibilities to promote public health and should be considered an important subsequent agreement
[Sean Flynn] Promoting research and access to its products has always been a core purpose of copyright law, often expressed in limitations and exceptions for research uses. Recent legal scholarship has examined the need for copyright exceptions for text and data mining (TDM) methodologies, and the doctrines recently enacted to achieve this purpose. Empirical scholarship has highlighted the positive impact
[Aram Sinnreich, Patricia Aufderheide, Maggie Clifford and Saif Shahin] Abstract: This article maps patterns of interest in key terms associated with copyright and online culture in the US context. Using exploratory factor analysis of data from Google Trends, authors examined patterns in keyword searches between 2004–2019. The data show three distinct periods of interest. The first period consists of utopian,
[Jonathan Band] In March 2015, I published The Complexity Dialectic: A Case Study From Copyright Law, where I argued that the nature of the U.S. political system encourages increasingly complex regulatory frameworks, which benefit those with more resources to navigate those frameworks. I used the triennial rulemaking under the Digital Millennium Copyright Act (“DMCA”) as a case study to demonstrate
[Reshma Ramachandran, Joseph S. Ross, and Jennifer E. Miller] The COVID-19 pandemic has led to the rapid development of multiple vaccines, tested in clinical trials located in several countries. Low- and middle-income countries have experienced significant delays in vaccine access despite initiatives aiming to ensure fair distribution, such as COVID-19 Vaccines Global Access (COVAX). Because pharmaceuticals do not receive consistent
[MPP Press Release] Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to life-saving medicines for low- and middle-income countries, today announced the signing of a voluntary license agreement for Pfizer’s COVID-19 oral antiviral treatment candidate PF-07321332, which is administered in combination with low dose ritonavir (PF-07321332; ritonavir). The agreement will enable
Posts by Category
- Video
- User Rights Network
- US Domestic Policies
- US Domestic Legislation
- Transparency
- Trade Agreements
- Takedown
- Trade Disputes
- Trademark
- Round-up
- Regional Fora
- Surveys and Data
- Positive Agenda
- Patent Pledges
- Open
- News
- Multilateral Fora
- Limitations and Exceptions
- IP & Research
- IP and Human Rights
- Industry Initiatives
- Flagged
- Fair Use
- Events
- Empirical Research
- Document Library
- Coronavirus
- Brazil
- Blog
- Bilateral Trade Pressures
- Artificial Intelligence
- AI
- Africa Group Work Plan Proposal
- Africa: Copyright & Public Interest
- Access to Medicine
- Academic Resources